GRI Bio, Inc.
GRI
$1.54
-$0.02-1.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.53% | -61.42% | 2.79% | 0.70% | 66.65% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -171.05% | -97.50% | 109.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 150.48% | 371.43% | 282.88% | -81.57% | -202.94% |
| Change in Net Operating Assets | -253.99% | 394.54% | 97.04% | -136.53% | -94.89% |
| Cash from Operations | -47.87% | 21.20% | 64.05% | -73.00% | -39.03% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.78% | -- | -- | -- | -59.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.68% | 99.01% | -102.47% | -- | 91.26% |
| Cash from Financing | 13.72% | -100.25% | -41.21% | -- | -25.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.61% | -176.52% | 116.79% | -22.58% | -47.87% |